Weekly Signal Report — May 02, 2026

📉 33 crossed below 📈 32 recovered

This week, 33 stocks crossed below their 200-week moving average — entering what we call “deep value territory.” This is the signal our screener is built to detect: quality companies trading below a price level that has historically represented a floor over the prior four years.

Not every stock that crosses the line is a buy. Some are cheap for good reason. The 200-week moving average is a starting point for research, not a buy signal. Below, we break down each new crossing with the context you need to decide whether it’s opportunity or a warning.

On the other side, 32 stocks climbed back above the line this week — exiting deep value territory.

What is deep value territory?

The 200-week moving average represents roughly four years of price history. When a stock drops below this level, it means the current price is lower than the average investor paid over the last four years. For quality companies, these moments are rare — most stocks only cross below the 200-week line a handful of times in their history.

Our data shows that while 12-month returns from a crossing can be modest, 24-month returns are often significantly higher. The strategy requires patience. Not every crossing is a buying opportunity — some stocks are cheap because the business is deteriorating. That's why we pair the signal with quality metrics like free cash flow trends, insider buying, and return on equity.

📉 Newly Below the Line

RBLX — Roblox Corporation

Communication Services - Gaming $32.3B
18.5% below $45.13 → 200WMA $55.40

Historical Context

This is the 4th time RBLX has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +31.5%. History favors the patient buyer here.

Quality Signals

📉 RSI 29 (Oversold) 💥 Capitulation Volume

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Oversold (RSI 29): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full RBLX analysis →

CHH — Choice Hotels International Inc.

Consumer Discretionary - Hotels $4.6B
14.8% below $100.70 → 200WMA $118.12

Historical Context

This is the 26th time CHH has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +28.4%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full CHH analysis →

SITE — SiteOne Landscape Supply Inc.

Industrials - Distribution $5.6B
9.9% below $125.61 → 200WMA $139.42

Historical Context

This is the 10th time SITE has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +52.6%. History favors the patient buyer here.

Quality Signals

📈 FCF Growing 💥 Capitulation Volume

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full SITE analysis →

SYK — Stryker Corporation

Healthcare - Medical Devices $112.9B
6.7% below $294.73 → 200WMA $315.98

Historical Context

This is the 22th time SYK has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +41.8%. History favors the patient buyer here.

Quality Signals

📈 FCF Growing

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full SYK analysis →

RMD — ResMed Inc.

Healthcare - Medical Instruments & Supplies $29.9B
5.9% below $205.02 → 200WMA $217.90

Historical Context

This is the 13th time RMD has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +30.4%. History favors the patient buyer here.

Quality Signals

🏆 Buffett Quality 📈 FCF Growing 📉 RSI 30 (Oversold) 💥 Capitulation Volume

Things to Watch

  • Oversold (RSI 30): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full RMD analysis →

GRAB — Grab Holdings Limited

Technology - Super App $15.0B
5.2% below $3.67 → 200WMA $3.87

Historical Context

This is the 4th time GRAB has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -39%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

💰 6% FCF Yield 🔄 Frequent Crosser — Weak Recoveries

Things to Watch

  • Cycling pattern: GRAB has crossed below the 200-week MA 4 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full GRAB analysis →

KBH — KB Home

Consumer Discretionary - Homebuilders $3.2B
4.9% below $51.44 → 200WMA $54.11

Historical Context

This is the 26th time KBH has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +37.2%. History favors the patient buyer here.

Quality Signals

💰 13.3% FCF Yield

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full KBH analysis →

HSY — The Hershey Company

Consumer Staples - Confectionery $37.0B
4.4% below $182.34 → 200WMA $190.82

Historical Context

This is the 12th time HSY has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +7.8%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: HSY has crossed below the 200-week MA 12 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full HSY analysis →

CAMP — CAMP4 THERAPEUTICS CORPORATION

Healthcare - Biotechnology $210M
4.4% below $4.05 → 200WMA $4.23

Historical Context

This is the 4th time CAMP has crossed below its 200-week moving average.

Quality Signals

🔍 Insider Buying ⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries

Things to Watch

  • RSI still elevated (50): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: CAMP has crossed below the 200-week MA 4 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full CAMP analysis →

AWK — American Water Works Company, Inc.

Utilities - Utilities - Regulated Water $24.9B
3.4% below $127.38 → 200WMA $131.90

Historical Context

This is the 13th time AWK has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +7.8%. History favors the patient buyer here.

Quality Signals

👑 Dividend Aristocrat ⚠️ FCF Declining

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: AWK has crossed below the 200-week MA 13 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full AWK analysis →

WTW — Willis Towers Watson Public Limited Company

Financial Services - Insurance Brokers $24.2B
3.3% below $256.34 → 200WMA $265.05

Historical Context

This is the 13th time WTW has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +23.1%. History favors the patient buyer here.

Quality Signals

🔍 Insider Buying 📈 FCF Growing 💰 8.5% FCF Yield

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full WTW analysis →

OLLI — Ollie's Bargain Outlet Holdings Inc.

Consumer Discretionary - Discount Retail $5.2B
2.6% below $85.61 → 200WMA $87.88

Historical Context

This is the 4th time OLLI has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +44.1%. History favors the patient buyer here.

Quality Signals

📈 FCF Growing 📉 RSI 27 (Oversold)

Things to Watch

  • Oversold (RSI 27): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full OLLI analysis →

HOV — Hovnanian Enterprises, Inc.

Consumer Cyclical - Residential Construction $656M
2.5% below $110.46 → 200WMA $113.27

Historical Context

This is the 30th time HOV has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +26.7%. History favors the patient buyer here.

Quality Signals

🎯 Yartseva Multibagger 📈 FCF Growing 💰 18% FCF Yield

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full HOV analysis →

AWR — American States Water Company

Utilities - Utilities - Regulated Water $2.9B
2.3% below $75.21 → 200WMA $76.95

Historical Context

This is the 32th time AWR has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +11.2%. History favors the patient buyer here.

Quality Signals

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • RSI still elevated (54): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full AWR analysis →

LXRX — Lexicon Pharmaceuticals, Inc.

Healthcare - Biotechnology $724M
2.2% below $1.63 → 200WMA $1.67

Historical Context

This is the 18th time LXRX has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -18%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

🔍 Insider Buying ⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: LXRX has crossed below the 200-week MA 18 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full LXRX analysis →

HD — The Home Depot Inc.

Consumer Discretionary - Home Improvement $322.6B
2.2% below $323.88 → 200WMA $331.05

Historical Context

This is the 24th time HD has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +32.2%. History favors the patient buyer here.

Quality Signals

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full HD analysis →

MDT — Medtronic plc

Healthcare - Medical Devices $102.7B
1.5% below $80.00 → 200WMA $81.23

Historical Context

This is the 29th time MDT has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +16.9%. History favors the patient buyer here.

Quality Signals

👑 Dividend Aristocrat ⚠️ FCF Declining 📉 RSI 16 (Oversold)

Things to Watch

  • Oversold (RSI 16): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full MDT analysis →

ITRI — Itron, Inc.

Technology - Scientific & Technical Instruments $3.8B
1.3% below $85.40 → 200WMA $86.56

Historical Context

This is the 21th time ITRI has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +27.8%. History favors the patient buyer here.

Quality Signals

📈 FCF Growing 💰 7.9% FCF Yield 📉 Distribution

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full ITRI analysis →

SPGI — S&P Global Inc.

Financial Services - Data & Analytics $126.1B
1.3% below $426.06 → 200WMA $431.71

Historical Context

This is the 16th time SPGI has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +19.6%. History favors the patient buyer here.

Quality Signals

👑 Dividend Aristocrat 🔍 Insider Buying 📈 FCF Growing

Things to Watch

  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full SPGI analysis →

SNY — Sanofi

Healthcare - Pharmaceuticals $110.4B
1.2% below $46.08 → 200WMA $46.66

Historical Context

This is the 20th time SNY has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +11.3%. History favors the patient buyer here.

Quality Signals

💰 15.1% FCF Yield ⚠️ FCF Declining

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full SNY analysis →

XYL — Xylem Inc.

Industrials - Water Equipment $27.4B
1.2% below $115.37 → 200WMA $116.76

Historical Context

This is the 10th time XYL has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +43.2%. History favors the patient buyer here.

Quality Signals

📈 FCF Growing 📉 RSI 29 (Oversold)

Things to Watch

  • Oversold (RSI 29): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full XYL analysis →

MIDD — The Middleby Corporation

Industrials - Food Equipment $6.5B
1.2% below $138.87 → 200WMA $140.51

Historical Context

This is the 28th time MIDD has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -2.6%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

🔍 Insider Buying 📈 FCF Growing 🔄 Frequent Crosser — Weak Recoveries

Things to Watch

  • Cycling pattern: MIDD has crossed below the 200-week MA 28 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full MIDD analysis →

RPM — RPM International Inc.

Materials - Coatings & Sealants $13.0B
1.1% below $101.34 → 200WMA $102.49

Historical Context

This is the 18th time RPM has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +23.7%. History favors the patient buyer here.

Quality Signals

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full RPM analysis →

MTH — Meritage Homes Corporation

Consumer Discretionary - Homebuilders $4.4B
1% below $66.34 → 200WMA $67.02

Historical Context

This is the 24th time MTH has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +51.1%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full MTH analysis →

STE — Steris plc

Healthcare - Medical Equipment $21.0B
1% below $214.40 → 200WMA $216.51

Historical Context

This is the 24th time STE has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +24.5%. History favors the patient buyer here.

Quality Signals

📈 FCF Growing 📉 RSI 24 (Oversold)

Things to Watch

  • Oversold (RSI 24): The stock is already deeply oversold on a weekly basis. This could mean a bounce is near, but it could also mean momentum is strongly negative. Don't catch a falling knife without a thesis.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full STE analysis →

BLFS — BioLife Solutions, Inc.

Healthcare - Medical Instruments & Supplies $1.0B
0.7% below $21.21 → 200WMA $21.36

Historical Context

This is the 24th time BLFS has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +61.8%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full BLFS analysis →

SONY — Sony Group Corporation

Consumer Discretionary - Electronics $116.9B
0.6% below $19.78 → 200WMA $19.91

Historical Context

This is the 48th time SONY has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +14.4%. History favors the patient buyer here.

Quality Signals

📈 FCF Growing

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full SONY analysis →

ALGT — Allegiant Travel Company

Industrials - Airlines $1.4B
0.5% below $75.02 → 200WMA $75.42

Historical Context

This is the 14th time ALGT has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +8.9%. History favors the patient buyer here.

Quality Signals

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cycling pattern: ALGT has crossed below the 200-week MA 14 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full ALGT analysis →

YMM — Full Truck Alliance Co. Ltd.

Technology - Freight Marketplace $9.0B
0.5% below $8.61 → 200WMA $8.65

Historical Context

This is the 5th time YMM has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +29.7%. History favors the patient buyer here.

Quality Signals

💰 35.4% FCF Yield

Things to Watch

  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full YMM analysis →

VKTX — Viking Therapeutics, Inc.

Healthcare - Metabolic Diseases $3.5B
0.4% below $30.00 → 200WMA $30.11

Historical Context

This is the 8th time VKTX has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +18.8%. History favors the patient buyer here.

Quality Signals

⚠️ FCF Declining

No quality flags detected. This stock crossed below the line without any of our positive quality signals — approach with extra caution.

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full VKTX analysis →

JBSS — John B. Sanfilippo & Son, Inc.

Consumer Defensive - Packaged Foods $931M
0.3% below $79.65 → 200WMA $79.91

Historical Context

This is the 15th time JBSS has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of -16.5%. History has not rewarded buying this stock at the 200-week line — extra caution warranted.

Quality Signals

🏆 Buffett Quality ⚠️ FCF Declining 🔄 Frequent Crosser — Weak Recoveries 💥 Capitulation Volume

Things to Watch

  • RSI still elevated (61): The stock just crossed below the line but isn't oversold yet. It may have further to fall before reaching a bottom.
  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • Cycling pattern: JBSS has crossed below the 200-week MA 15 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full JBSS analysis →

VFC — VF Corporation

Consumer Discretionary - Apparel $7.4B
0.3% below $19.01 → 200WMA $19.07

Historical Context

This is the 21th time VFC has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +14.1%. History favors the patient buyer here.

Quality Signals

🔍 Insider Buying 💰 10.5% FCF Yield ⚠️ FCF Declining

Things to Watch

  • Cash flow is deteriorating: Free cash flow is trending downward. The stock might be cheap for a reason — verify whether this is a temporary or structural issue.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full VFC analysis →

AVNT — Avient Corporation

Materials - Specialty Polymers $3.4B
0% below $36.76 → 200WMA $36.77

Historical Context

This is the 29th time AVNT has crossed below its 200-week moving average. Previous crossings produced an average 1-year return of +4.1%. History favors the patient buyer here.

Quality Signals

💰 9.9% FCF Yield 🔄 Frequent Crosser — Weak Recoveries

Things to Watch

  • Cycling pattern: AVNT has crossed below the 200-week MA 29 times with modest average returns. This stock may oscillate around the line rather than bounce decisively — consider whether this is a value trap.
  • No quality floor: This stock doesn't pass our Buffett quality screen or have a long dividend track record. The business quality is less certain, which means the 200-week MA crossing carries less predictive weight.
  • The 200-week moving average is a starting point, not a buy signal. Always research the company's fundamentals, competitive position, and recent news before acting.
View full AVNT analysis →

📈 Recovered Above the Line

These stocks climbed back above their 200-week moving average this week. If you bought during their time below the line, this is a milestone — though not necessarily a sell signal.

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.